Back to School: How biopharma can reboot drug development. Access exclusive analysis here
SHP purchased DAX's Canadian pharmaceuticals sales and marketing division, Draxis Pharmaceutica, for
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury